English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3026]
News [6111]
Articles [120]
Editorials [18]
Conferences [179]
elearning [32]
Black cancer patients 71% more likely to experience heart damage following chemotherapy treatment
Black cancer patients 71% more likely to experience heart damage following chemotherapy treatment
Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence
Adding new vaccine type to leading immunotherapy dramatically reduced melanoma recurrence
Personalised immunotherapy to fight deadly brain tumours
Personalised immunotherapy to fight deadly brain tumours
Researchers identify promising new target for drug-resistant breast and ovarian cancers
Researchers identify promising new target for drug-resistant breast and ovarian cancers
Study unravels pathophysiological role of Dectin-1 in promoting colorectal cancer
Study unravels pathophysiological role of Dectin-1 in promoting colorectal cancer
Antisense oligonucleotide therapy may be a new potential treatment for H3.3K27M diffuse midline glioma
Antisense oligonucleotide therapy may be a new potential treatment for H3.3K27M diffuse midline glioma
The riddle of cachexia – scientists move one step closer towards understanding the devastating loss of fat and muscle during cancer
The riddle of cachexia – scientists move one step closer towards understanding the devastating loss of fat and...
Precision magnetics could be game-changer for therapy-resistant brain cancers
Precision magnetics could be game-changer for therapy-resistant brain cancers
FDA converts to full approval indication for pembrolizumab for certain adult and paediatric patients with advanced microsatellite instability-High (MSI-H) or mismatch repair deficient (dMMR) solid tumours
FDA converts to full approval indication for pembrolizumab for certain adult and paediatric patients with advanced...
ICR hails ‘momentous’ recommendation of olaparib for breast and prostate cancer
ICR hails ‘momentous’ recommendation of olaparib for breast and prostate cancer
<1...105106107108109...612>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top